ArticleChild psychiatry and human development2025
Treatment Approaches and Growth Parameters in Pediatric ADHD: Examining Differences Across Race.
Article in Child psychiatry and human development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Racial disparities in diagnosis and treatment of pediatric mental health conditions are well-documented. Stimulants are the cornerstone of ADHD treatment, but long-term effects on growth remain a concern. We retrospectively analyzed treatment history (e.g., duration, medication, comorbidity), growth, and demographics (e.g., socioeconomic status and race) from 197 pediatric patients with ADHD. We found Black and Hispanic patients were younger, had lower socioeconomic status, and were followed for longer than White patients. Despite similar amounts of comorbidities across racial groups, White patients received more antidepressants (p < 0.001). Stimulant users were prescribed fewer atomoxetine, antidepressant, and antipsychotic medications but had longer follow-up and more total medications. We saw a significant decrease in height Z-scores for the whole cohort, and an increase in BMI Z-scores in Hispanic patients. The findings highlight disparities in pharmacological treatment of pediatric patients with ADHD and more research is needed to understand factors contributing to potential biases to reduce inequities in care and improve patient outcomes.
Indexed as
Identifiers
40991105What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.